Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kneat.com Inc T.KSI

Alternate Symbol(s):  KSIOF

Healthcare Medical Devices
kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Company’s focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Company’s product is Kneat Gx, a... see more

Recent & Breaking News (TSX:KSI)

Kneat Announces Record SaaS Revenue in Q3 2022

Canada NewsWire November 9, 2022

Kneat Announces Release Date for 2022 Third Quarter Financial Results

Canada NewsWire November 7, 2022

Top Tier Fortune 500 Healthcare Company Selects Kneat

Canada NewsWire October 27, 2022

Kneat Announces Record SaaS Revenue in Q2 2022

Canada NewsWire August 10, 2022

Kneat Announces Release Date for 2022 Second Quarter Financial Results

Canada NewsWire August 5, 2022

Kneat to Present at the Canaccord Genuity 42nd Annual Growth Conference

Canada NewsWire July 28, 2022

Kneat Adds Accomplished Global Sales Leader to its Executive Team

Canada NewsWire June 14, 2022

Kneat Announces Results of Voting at Annual General and Special Meeting

Canada NewsWire June 1, 2022

Kneat Announces Record SaaS Revenue in Q1 2022

Canada NewsWire May 11, 2022

Kneat Announces Release Date for 2022 First Quarter Financial Results

Canada NewsWire May 9, 2022

Toronto Stock Exchange, Kneat.com Inc., The View From The C-Suite

Canada NewsWire April 8, 2022

Kneat Announces OTCQX Listing and DTC Eligibility

Canada NewsWire March 31, 2022

OTC Markets Group Welcomes kneat.com, Inc. to OTCQX

GlobeNewswire March 31, 2022

European National Health Service Selects Kneat's eValidation Platform

Canada NewsWire March 18, 2022

Top Ten Biopharmaceutical Company Selects Kneat as its Enterprise Platform

Canada NewsWire March 17, 2022

Leading Canadian Generics Pharmaceutical Manufacturer Selects Kneat's SaaS E-Validation Platform

Canada NewsWire March 10, 2022

Ireland's Third Fastest Growing Technology Company to Announce up to 100 New Jobs at Opening of New Limerick Office

Canada NewsWire March 4, 2022

Kneat Announces Record Fourth Quarter Revenues and Full Year 2021 Results

PR Newswire February 23, 2022

Kneat Announces Release Date for 2021 Fourth Quarter and Fiscal Year Financial Results

PR Newswire February 22, 2022

Kneat Announces Changes to Board of Directors

PR Newswire January 31, 2022